BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38643936)

  • 1. Hybrid adipocyte-derived exosome nano platform for potent chemo-phototherapy in targeted hepatocellular carcinoma.
    Liu X; Zhang J; Zheng S; Li M; Xu W; Shi J; Kamei KI; Tian C
    J Control Release; 2024 Jun; 370():168-181. PubMed ID: 38643936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment.
    Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
    Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
    Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
    Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma.
    Wang J; Zhuo J; Tao Y; Xu S; Chen Z; Yang F; Ke Q; Xie H; Zheng S; Wang H; Xu X
    Int J Nanomedicine; 2020; 15():6839-6854. PubMed ID: 32982236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifunctional nano-delivery system enhances the chemo-
    Zhao R; Ning X; Wang M; Yu A; Wang Y
    J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Exosome-Like Nanovesicles Derived from
    Zhang L; He F; Gao L; Cong M; Sun J; Xu J; Wang Y; Hu Y; Asghar S; Hu L; Qiao H
    Int J Nanomedicine; 2021; 16():1575-1586. PubMed ID: 33664572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy.
    Guo D; Xu S; Wang N; Jiang H; Huang Y; Jin X; Xue B; Zhang C; Zhu X
    Biomaterials; 2017 Nov; 144():188-198. PubMed ID: 28837960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
    Duan W; Liu Y
    Drug Des Devel Ther; 2018; 12():2149-2161. PubMed ID: 30034219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Yu XN; Deng Y; Zhang GC; Liu J; Liu TT; Dong L; Zhu CF; Shen XZ; Li YH; Zhu JM
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17193-17206. PubMed ID: 32207914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma.
    Abuduwaili W; Wang X; Huang AT; Sun JL; Xu RC; Zhang GC; Liu ZY; Wang F; Zhu CF; Liu TT; Dong L; Zhu JM; Weng SQ; Li Y; Shen XZ
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37356-37368. PubMed ID: 35951459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.
    Guo J; Yu Z; Sun D; Zou Y; Liu Y; Huang L
    Mol Cancer; 2021 Jan; 20(1):10. PubMed ID: 33407548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.
    Wang D; Zhang S; Zhang T; Wan G; Chen B; Xiong Q; Zhang J; Zhang W; Wang Y
    Int J Nanomedicine; 2017; 12():8649-8670. PubMed ID: 29255359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
    Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
    Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB/ROS signaling.
    Zhang Z; Li D; Cao Y; Wang Y; Wang F; Zhang F; Zheng S
    Int Immunopharmacol; 2021 Oct; 99():107624. PubMed ID: 34343939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.
    Rango E; D'Antona L; Iovenitti G; Brai A; Mancini A; Zamperini C; Trivisani CI; Marianelli S; Fallacara AL; Molinari A; Cianciusi A; Schenone S; Perrotti N; Dreassi E; Botta M
    Eur J Med Chem; 2021 Nov; 223():113653. PubMed ID: 34161866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.